Ovarian cancer is the leading cause of death in gynecological malignancies. The majority of patients with ovarian cancer are identified at advanced stages of the disease and eventually die of disease ...
Preliminary safety results of an ongoing phase I/II clinical study of MGN1601, a tumor vaccine comprising allogeneic, gene-modified, and irradiated tumor cells in combination with an immunomodulator ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results